Search PDMR transactions

Notifier
Name of person with notification obligation
Quantass ApS
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Jeppe Øvli Øvlesen
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Synact Pharma AB
Issuer’s LEI code
549300RRYIEFEQ72N546
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Synact Pharma AB SE0008241491 Merger decrease 1,456,263 Quantity 0.00 SEK 06/01/2021 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Synact Pharma AB SE0008241491 Merger decrease 06/01/2021 Outside a trading venue 1,456,263 (Quantity) 0.00 SEK
Total: 1,456,263
<< Back